Adverse Events in Total Artificial Heart for End-Stage Heart Failure: Insight From the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE)
| No | 이름 | 이메일 | 기관 |
|---|---|---|---|
| 1 | Min Choon Tan | - | Division of Cardiovascular Medicine, Mayo Clinic Arizona |
| 2 | Yong Hao Yeo | - | Department of Internal Medicine, Beaumont Health |
| 3 | Jia Wei Tham | - | Perdana University-Royal College of Surgeons in Ireland |
| 4 | Jian Liang Tan | - | Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania |
| 5 | Hee Kong Fong | - | Division of Cardiovascular Medicine, UC Davis Medical Center |
| 6 | Bryan E-Xin Tan | - | Department of Internal Medicine, Rochester General Hospital |
| 7 | Kwan S Lee | - | Division of Cardiovascular Medicine, Mayo Clinic Arizona |
| 8 | Justin Z Lee | - | Division of Cardiovascular Medicine, Cleveland Clinic |